SCHEMBL20418878

SCHEMBL20418878

CCOC(=O)C(=CNc1cc(C)nn1Cc1cc(C)cc(C)n1)C(=O)OCC

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.58
NPSR1 Q6W5P4 4/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
LMNA P02545 2/20 0.54
STAT1 P42224 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
NPY1R P25929 1/20 0.53
NPY2R P49146 1/20 0.53
DHODH Q02127 4/20 0.43
MAPT P10636 3/20 0.41
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20413748 0.89 GAA (0.46) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL583369 0.82 GAA (0.70) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL17963146 0.80 GAA (0.67) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL17963372 0.80 GAA (0.57) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL17963296 0.79 GAA (0.60) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL17963246 0.77 GAA (0.60) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL17963231 0.77 GAA (0.56) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL582277 0.76 GAA (0.72) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL31023675 0.76 GAA (0.65) GAANPSR1SMN1; SMN2LMNASTAT1
SCHEMBL17963068 0.76 GAA (0.61) GAANPSR1SMN1; SMN2LMNASTAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10272074-B2 Inhibitors of glucocorticoid receptor translocation Sanford Burnham Prebys Medical Discovery Institute (US) 2019-04-30 US disclosed
US-20180207140-A1 Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation Sanford Burnham Prebys Medical Discovery Institute 2018-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180207140-A1 Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation NR3C1, NR3C2, GRK3 GAA 2062/4885NPSR1 679/4885SMN1; SMN2 4568/4885
US-10272074-B2 Inhibitors of glucocorticoid receptor translocation NR3C1, NR3C2, GRK3 GAA 1401/4885NPSR1 408/4885SMN1; SMN2 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.